Impax Labs Inc Drug Patent Portfolio
Impax Labs Inc's Family Patents
Recently granted tentative Approvals to Impax Labs Inc
These tentative approvals reflect continued regulatory progress across both innovative and generic submissions related to Impax Labs Inc's portfolio.
Generic tentative approvals
| Drug Name | Active Ingredient | Submission Type | Submission Category | Submission Date |
|---|---|---|---|---|
| Duloxetine Hydrochloride | Duloxetine Hydrochloride |
ORIG-1
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | (Not Available) | 18 Nov, 2010 |
| Venlafaxine Hydrochloride | Venlafaxine Hydrochloride |
ORIG-1
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | (Not Available) | 16 Oct, 2007 |
| Oxycodone Hydrochloride | Oxycodone Hydrochloride |
ORIG-1
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | (Not Available) | 04 Sep, 2003 |
Explore deeper patents analysis
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List